Blood cholesterol reducing pharmaceutical composition
First Claim
Patent Images
1. A salt comprising the reaction product of nicotinic acid and a basic anion exchange resin having a degree of crosslinking with divinylbenzene of less than about 4%, a maximum degree of crosslinking corresponding to a minimum moisture content of 50%, and a particle size in water in a swollen, chloride form ranging from about 0.03 to about 0.84 mm.
2 Assignments
0 Petitions
Accused Products
Abstract
A salt comprising the reaction product of nicotinic acid and an anion exchange resin having a degree of crosslinking with divinylbenzene of less than 4%. These salts are useful in reducing blood cholesterol levels.
34 Citations
6 Claims
- 1. A salt comprising the reaction product of nicotinic acid and a basic anion exchange resin having a degree of crosslinking with divinylbenzene of less than about 4%, a maximum degree of crosslinking corresponding to a minimum moisture content of 50%, and a particle size in water in a swollen, chloride form ranging from about 0.03 to about 0.84 mm.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeRobert Kunin
-
Original AssigneeRutgers University
-
InventorsKunin, Robert
-
Primary Examiner(s)Page, Thurman K.
-
Assistant Examiner(s)Spear, James M.
-
Application NumberUS07/939,990Time in Patent Office2,273 DaysField of Search424/78.1, 424/483, 424/484, 424/489, 424/490, 424/497US Class Current424/489CPC Class CodesA61K 47/585 Ion exchange resins, e.g. p...
